XML 73 R60.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Joint Venture - Additional Information (Detail)
12 Months Ended
Aug. 09, 2019
Individual
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Schedule Of Equity Method Investments [Line Items]      
Net loss attributable to noncontrolling interest   $ 1,371,000 $ 68,000
Arcadia Biosciences, Inc [Member] | Archipelago Ventures Hawaii, LLC [Member]      
Schedule Of Equity Method Investments [Line Items]      
Number of individuals appointed | Individual 2    
Joint venture interest percentage   50.75%  
Capital contributions   $ 2,336,000  
Legacy Ventures Hawaii, LLC [Member] | Archipelago Ventures Hawaii, LLC [Member]      
Schedule Of Equity Method Investments [Line Items]      
Number of individuals appointed | Individual 2    
Joint venture interest percentage   49.25%  
Capital contributions   $ 2,267,000